Division of Gastroenterology & Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, USA.
Sci Rep. 2022 Jun 11;12(1):9679. doi: 10.1038/s41598-022-13943-2.
Measuring the adenoma detection rate (ADR) is critical to providing quality care, however it is also challenging. We aimed to develop a tool using pre-existing electronic health record (EHR) functions to accurately and easily measure total ADR and to provide real-time feedback for endoscopists. We utilized the Epic EHR. With the help of an Epic analyst, using existing tools, we developed a method by which endoscopy staff could mark whether an adenoma was detected for a given colonoscopy. Using these responses and all colonoscopies performed by the endoscopist recorded in the EHR, ADR was calculated in a report and displayed to endoscopists within the EHR. One endoscopist piloted the tool, and results of the tool were validated against a manual chart review. Over the pilot period the endoscopist performed 145 colonoscopies, of which 78 had adenomas. The tool correctly identified 76/78 colonoscopies with an adenoma and 67/67 of colonoscopies with no adenomas (97.4% sensitivity, 100% specificity, 98% accuracy). There was no difference in ADR as determined by the tool compared to manual review (53.1% vs. 53.8%, p = 0.912). We successfully developed and pilot tested a tool to measure ADR using existing EHR functionality.
测量腺瘤检出率(ADR)对于提供高质量的医疗服务至关重要,但这也是一项具有挑战性的工作。我们旨在开发一种使用现有电子健康记录(EHR)功能的工具,以便准确、轻松地测量总 ADR,并为内镜医生提供实时反馈。我们利用了 Epic EHR。在 Epic 分析师的帮助下,使用现有的工具,我们开发了一种方法,内镜工作人员可以用这种方法标记给定结肠镜检查中是否发现了腺瘤。根据这些回答以及 EHR 中记录的内镜医生进行的所有结肠镜检查,在报告中计算 ADR,并在 EHR 中向内镜医生显示。一名内镜医生试用了该工具,并将工具的结果与手动图表审查进行了验证。在试点期间,该内镜医生进行了 145 例结肠镜检查,其中 78 例有腺瘤。该工具正确识别出了 76/78 例有腺瘤的结肠镜检查和 67/67 例无腺瘤的结肠镜检查(敏感性为 97.4%,特异性为 100%,准确性为 98%)。与手动审查相比,工具确定的 ADR 没有差异(53.1%与 53.8%,p=0.912)。我们成功开发并试用了一种使用现有 EHR 功能来测量 ADR 的工具。